Epilepsy Study Further Bolsters Case for Newly Developed Gene Therapy
Research suggests how a newly developed gene therapy can treat Dravet syndrome, a severe form of epilepsy, and potentially prolong survival for people with the condition.
“Decoy” Protein Effective Against SARS-CoV-2 Variants in Mouse Study
According to a study, a drug treatment that acts as a decoy against SARS-CoV-2 was highly effective at preventing death and lung damage in humanized animal models of severe COVID-19 disease.
Omicron Recognized by T Cells From Previous Infection or Vaccination
Memory T cells generated after COVID-19 infection or mRNA vaccination are able to recognize the omicron variant of SARS-CoV-2.
Yale Scientists Track Lifespan and Functions of mRNA
It took a global pandemic, but the critical role of messenger RNA in all of life’s functions has taken center stage in the past year with the successful rollout of mRNA vaccines to combat the SARS-Cov-2 virus.
Bilateral Tumor Model Created To Investigate Anticancer T-Cell Responses
Scientists have shown that a bilateral tumor model could be useful to investigate the relationship between T-cell repertoire and the therapeutic effects of cancer immunotherapy.
Antibody Drug for COVID-19 Passes Phase 2 Clinical Trial
A new drug that targets the cytokine storm associated with severe COVID-19 disease has passed its phase two clinical trial.
Who Should Be Vaccinated First To Prevent Spread of New Variants?
A theoretical framework has been published that assesses the impact of various vaccination strategies on the rate of emergence for new variants.
Progress in Developing Universal Vaccines Against Harmful Pathogens
University of Wisconsin–Madison researchers and their collaborators are making progress toward developing universal vaccines against some the planet’s most harmful pathogens, including the virus family responsible for the COVID-19 pandemic.
Rhesus Macaque Study Makes Strides Towards a Schistosomiasis Vaccine
A research group has discovered the mechanism by which the Rhesus macaque Macaca mulatta naturally develops a lasting immune response against schistosomiasis.
BCG Vaccine Could Assist Future COVID-19 Vaccine Development
A computational biology researcher has reported a cross-reaction between Bacillus Calmette-Guérin and SARS-CoV-2 that might help explain what could be driving immunity brought on by the BCG vaccination.